exosomes

Review of where Kimera Labs fits into sphere of exosome companies

/ / 4 Comments
Kimera labs exosome

Today’s post takes a close look at the exosome manufacturer Kimera Labs in the context of the main exosome companies. What are exosomes? Exosomes are microscopic bubbles or vesicles produced by cells. Exosomes contain many cellular substances that are biologically active. Some of these materials may be helpful clinically, while others could pose risks. Clinical outcomes […]

Review of where Kimera Labs fits into sphere of exosome companies Read More »

Q&A with Roxland on stem cell clinic suits by Iowa & Nebraska

/ / Leave a Comment
beth-roxland

I wrote last week about the Nebraska and Iowa state Attorney Generals filing lawsuits against stem cell clinic firms and three individuals also named as defendants. Although I went into detail about the individuals including leader Travis Autor and the firms, I didn’t yet go into much depth on the state lawsuits themselves in that

Q&A with Roxland on stem cell clinic suits by Iowa & Nebraska Read More »

2 State AG’s sue ‘Stem Cell Centers’ clinics including for alleged fraud

/ / 2 Comments
Travis-Autor

Some readers suggested earlier this year that I look into a clinic firm called ‘Stem Cell Centers’ with its owner Travis Autor. I didn’t have time to do much since I’ve been very busy in the lab before the state Attorney Generals of Iowa and Nebraska sued them based on a number of allegations including

2 State AG’s sue ‘Stem Cell Centers’ clinics including for alleged fraud Read More »

Getting 30 F grades? FDA Strongly Warns Exosome Firm EUCYT

/ / 7 Comments
EUCYT-CEO-Travis-Bird

The FDA dropped a lengthy, extremely critical warning letter on a supplier of unproven exosome product called EUCYT Laboratories. For broader context, exosome therapy has somehow burst onto the scene when there’s no good data yet in my view to back up its use in the clinic. The FDA is taking notice with letters already sent

Getting 30 F grades? FDA Strongly Warns Exosome Firm EUCYT Read More »

As clinics buzz about coronavirus, COVID19 patient given non-FDA-approved exosomes?

/ / 4 Comments
Kimera-Labs-exosomes-COVID-19-novel-coronavirus-disease

When the number of stem cell clinical studies and trials listed for COVID-19 first started spiraling upward it seemed likely that stem cell clinics and other firms in that arena would get interested. I thought that we’d see the unproven regenerative medicine coronavirus bandwagon quickly grow. Unfortunately, there are reasons to be increasingly concerned here. For instance,

As clinics buzz about coronavirus, COVID19 patient given non-FDA-approved exosomes? Read More »

FDA needs to act boldly on unproven exosome therapies

/ / 3 Comments
exosomes-visualized-by-EM

The FDA needs to do more about clinics and suppliers of unproven “exosome therapies.” FDA on exosome therapies Dubious exosomes are sadly just the newest gimmick for some firms in the stem cell/regenerative medicine clinic arena right now. They are available at many stem cell and other clinics right now, but who knows what’s in

FDA needs to act boldly on unproven exosome therapies Read More »

Liveyon is back (again) with unproven exosome product

/ / 11 Comments
Liveyon

Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as

Liveyon is back (again) with unproven exosome product Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.